HPV Educational Intervention to Increase Acceptance and Completion Rate of Free HPV Vaccination Among Underserved Adult Patients

Overview

About this study

This phase IV trial examines the impact of an education program on the human papilloma virus (HPV) and its effects on the acceptance and completion rates of a free HPV vaccination program in underserved adult patients. Participating in the HPV educational program may increase the HPV vaccination rates among low income uninsured adult patients and ultimately prevent HPV related cancers.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria: -Patient of VIM clinic -No history of HPV vaccination -No history of allergy to HPV vaccination contents -Willingness to participate in clinical trial -For female patients, no history of positive HPV testing or abnormal Papanicolaou (Pap) smears -Patients who read and understand English Exclusion Criteria: -Individuals who had previously received the HPV vaccine

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Gerardo Colon-Otero, M.D.

Open for enrollment

Contact information:

Monica Albertie M.H.A.

(904)953-2693

Albertie.Monica@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20502616

Mayo Clinic Footer